Vasopressin inhibits diuresis induced by water immersion in humans.
Identifieur interne : 000224 ( Ncbi/Merge ); précédent : 000223; suivant : 000225Vasopressin inhibits diuresis induced by water immersion in humans.
Auteurs : S. Farrow [États-Unis] ; G. Banta ; S. Schallhorn ; R. May ; A. Mers ; L. Cadaret ; L. Rydstedt ; W. LocketteSource :
- Journal of applied physiology (Bethesda, Md. : 1985) [ 8750-7587 ] ; 1992.
Descripteurs français
- KwdFr :
- MESH :
- pharmacologie : Desmopressine.
- physiologie : Diurèse, Natriurèse, Volume sanguin.
- physiopathologie : Immersion.
- sang : Aldostérone, Facteur atrial natriurétique.
- Adulte, Adulte d'âge moyen, Diurèse, Humains, Mâle, Natriurèse, Volume sanguin.
English descriptors
- KwdEn :
- Adult, Aldosterone (blood), Atrial Natriuretic Factor (blood), Blood Volume (drug effects), Blood Volume (physiology), Deamino Arginine Vasopressin (pharmacology), Diuresis (drug effects), Diuresis (physiology), Humans, Immersion (physiopathology), Male, Middle Aged, Natriuresis (drug effects), Natriuresis (physiology).
- MESH :
- chemical , blood : Aldosterone, Atrial Natriuretic Factor.
- drug effects : Blood Volume, Diuresis, Natriuresis.
- chemical , pharmacology : Deamino Arginine Vasopressin.
- physiology : Blood Volume, Diuresis, Natriuresis.
- physiopathology : Immersion.
- Adult, Humans, Male, Middle Aged.
Abstract
We tested the hypothesis that 1-desamino-8-D-arginine vasopressin (DDAVP), a V2-receptor agonist, could inhibit the diuresis induced by water immersion in humans. Water and electrolyte excretion, plasma atrial natriuretic factor concentration, and plasma aldosterone concentration were measured initially and after 3 h of water immersion in 13 healthy sodium-replete men given either placebo or 20 micrograms of intranasal DDAVP. Guanosine 3',5'-cyclic monophosphate and urea excretion and urine osmolality were also determined. DDAVP inhibited the diuresis induced by water immersion in men: 758 +/- 168 (SE) ml/3 h in the placebo group vs. 159 +/- 28 ml/3 h in the DDAVP group (P less than 0.05). After 3 h of water immersion, plasma atrial natriuretic factor concentrations were increased from 11 +/- 2 to 20 +/- 4 pg/ml in the placebo group and from 14 +/- 2 to 33 +/- 4 pg/ml in the DDAVP group (P less than 0.05). Plasma aldosterone concentrations were decreased from 98 +/- 18 to 45 +/- 6 pg/ml in the placebo group (P less than 0.05) and from 54 +/- 17 to 25 +/- 5 pg/ml in the DDAVP group (P less than 0.05). Despite these changes in aldosterone and atrial natriuretic factor concentrations, which should increase sodium excretion, DDAVP decreased the natriuresis induced by water immersion in humans: 56 +/- 8 meq Na+/3 h in the placebo group vs. 36 +/- 6 meq Na+/3 h in the DDAVP group (P less than 0.05). DDAVP may be used to prevent the diuresis associated with central redistribution of blood volumes that occur during water immersion.(ABSTRACT TRUNCATED AT 250 WORDS)
DOI: 10.1152/jappl.1992.73.3.932
PubMed: 1400058
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002948
- to stream PubMed, to step Curation: 002948
- to stream PubMed, to step Checkpoint: 002786
Links to Exploration step
pubmed:1400058Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Vasopressin inhibits diuresis induced by water immersion in humans.</title><author><name sortKey="Farrow, S" sort="Farrow, S" uniqKey="Farrow S" first="S" last="Farrow">S. Farrow</name><affiliation wicri:level="2"><nlm:affiliation>Wayne State University School of Medicine, Detroit, Michigan 48201.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Wayne State University School of Medicine, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Banta, G" sort="Banta, G" uniqKey="Banta G" first="G" last="Banta">G. Banta</name></author><author><name sortKey="Schallhorn, S" sort="Schallhorn, S" uniqKey="Schallhorn S" first="S" last="Schallhorn">S. Schallhorn</name></author><author><name sortKey="May, R" sort="May, R" uniqKey="May R" first="R" last="May">R. May</name></author><author><name sortKey="Mers, A" sort="Mers, A" uniqKey="Mers A" first="A" last="Mers">A. Mers</name></author><author><name sortKey="Cadaret, L" sort="Cadaret, L" uniqKey="Cadaret L" first="L" last="Cadaret">L. Cadaret</name></author><author><name sortKey="Rydstedt, L" sort="Rydstedt, L" uniqKey="Rydstedt L" first="L" last="Rydstedt">L. Rydstedt</name></author><author><name sortKey="Lockette, W" sort="Lockette, W" uniqKey="Lockette W" first="W" last="Lockette">W. Lockette</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="1992">1992</date><idno type="RBID">pubmed:1400058</idno><idno type="pmid">1400058</idno><idno type="doi">10.1152/jappl.1992.73.3.932</idno><idno type="wicri:Area/PubMed/Corpus">002948</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002948</idno><idno type="wicri:Area/PubMed/Curation">002948</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002948</idno><idno type="wicri:Area/PubMed/Checkpoint">002786</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002786</idno><idno type="wicri:Area/Ncbi/Merge">000224</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Vasopressin inhibits diuresis induced by water immersion in humans.</title><author><name sortKey="Farrow, S" sort="Farrow, S" uniqKey="Farrow S" first="S" last="Farrow">S. Farrow</name><affiliation wicri:level="2"><nlm:affiliation>Wayne State University School of Medicine, Detroit, Michigan 48201.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Michigan</region></placeName><wicri:cityArea>Wayne State University School of Medicine, Detroit</wicri:cityArea></affiliation></author><author><name sortKey="Banta, G" sort="Banta, G" uniqKey="Banta G" first="G" last="Banta">G. Banta</name></author><author><name sortKey="Schallhorn, S" sort="Schallhorn, S" uniqKey="Schallhorn S" first="S" last="Schallhorn">S. Schallhorn</name></author><author><name sortKey="May, R" sort="May, R" uniqKey="May R" first="R" last="May">R. May</name></author><author><name sortKey="Mers, A" sort="Mers, A" uniqKey="Mers A" first="A" last="Mers">A. Mers</name></author><author><name sortKey="Cadaret, L" sort="Cadaret, L" uniqKey="Cadaret L" first="L" last="Cadaret">L. Cadaret</name></author><author><name sortKey="Rydstedt, L" sort="Rydstedt, L" uniqKey="Rydstedt L" first="L" last="Rydstedt">L. Rydstedt</name></author><author><name sortKey="Lockette, W" sort="Lockette, W" uniqKey="Lockette W" first="W" last="Lockette">W. Lockette</name></author></analytic><series><title level="j">Journal of applied physiology (Bethesda, Md. : 1985)</title><idno type="ISSN">8750-7587</idno><imprint><date when="1992" type="published">1992</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Aldosterone (blood)</term><term>Atrial Natriuretic Factor (blood)</term><term>Blood Volume (drug effects)</term><term>Blood Volume (physiology)</term><term>Deamino Arginine Vasopressin (pharmacology)</term><term>Diuresis (drug effects)</term><term>Diuresis (physiology)</term><term>Humans</term><term>Immersion (physiopathology)</term><term>Male</term><term>Middle Aged</term><term>Natriuresis (drug effects)</term><term>Natriuresis (physiology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Aldostérone (sang)</term><term>Desmopressine (pharmacologie)</term><term>Diurèse ()</term><term>Diurèse (physiologie)</term><term>Facteur atrial natriurétique (sang)</term><term>Humains</term><term>Immersion (physiopathologie)</term><term>Mâle</term><term>Natriurèse ()</term><term>Natriurèse (physiologie)</term><term>Volume sanguin ()</term><term>Volume sanguin (physiologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Aldosterone</term><term>Atrial Natriuretic Factor</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Blood Volume</term><term>Diuresis</term><term>Natriuresis</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Desmopressine</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Deamino Arginine Vasopressin</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Diurèse</term><term>Natriurèse</term><term>Volume sanguin</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Blood Volume</term><term>Diuresis</term><term>Natriuresis</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Immersion</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Immersion</term></keywords><keywords scheme="MESH" qualifier="sang" xml:lang="fr"><term>Aldostérone</term><term>Facteur atrial natriurétique</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte</term><term>Adulte d'âge moyen</term><term>Diurèse</term><term>Humains</term><term>Mâle</term><term>Natriurèse</term><term>Volume sanguin</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We tested the hypothesis that 1-desamino-8-D-arginine vasopressin (DDAVP), a V2-receptor agonist, could inhibit the diuresis induced by water immersion in humans. Water and electrolyte excretion, plasma atrial natriuretic factor concentration, and plasma aldosterone concentration were measured initially and after 3 h of water immersion in 13 healthy sodium-replete men given either placebo or 20 micrograms of intranasal DDAVP. Guanosine 3',5'-cyclic monophosphate and urea excretion and urine osmolality were also determined. DDAVP inhibited the diuresis induced by water immersion in men: 758 +/- 168 (SE) ml/3 h in the placebo group vs. 159 +/- 28 ml/3 h in the DDAVP group (P less than 0.05). After 3 h of water immersion, plasma atrial natriuretic factor concentrations were increased from 11 +/- 2 to 20 +/- 4 pg/ml in the placebo group and from 14 +/- 2 to 33 +/- 4 pg/ml in the DDAVP group (P less than 0.05). Plasma aldosterone concentrations were decreased from 98 +/- 18 to 45 +/- 6 pg/ml in the placebo group (P less than 0.05) and from 54 +/- 17 to 25 +/- 5 pg/ml in the DDAVP group (P less than 0.05). Despite these changes in aldosterone and atrial natriuretic factor concentrations, which should increase sodium excretion, DDAVP decreased the natriuresis induced by water immersion in humans: 56 +/- 8 meq Na+/3 h in the placebo group vs. 36 +/- 6 meq Na+/3 h in the DDAVP group (P less than 0.05). DDAVP may be used to prevent the diuresis associated with central redistribution of blood volumes that occur during water immersion.(ABSTRACT TRUNCATED AT 250 WORDS)</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">1400058</PMID><DateCompleted><Year>1992</Year><Month>11</Month><Day>23</Day></DateCompleted><DateRevised><Year>2017</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">8750-7587</ISSN><JournalIssue CitedMedium="Print"><Volume>73</Volume><Issue>3</Issue><PubDate><Year>1992</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Journal of applied physiology (Bethesda, Md. : 1985)</Title><ISOAbbreviation>J. Appl. Physiol.</ISOAbbreviation></Journal><ArticleTitle>Vasopressin inhibits diuresis induced by water immersion in humans.</ArticleTitle><Pagination><MedlinePgn>932-6</MedlinePgn></Pagination><Abstract><AbstractText>We tested the hypothesis that 1-desamino-8-D-arginine vasopressin (DDAVP), a V2-receptor agonist, could inhibit the diuresis induced by water immersion in humans. Water and electrolyte excretion, plasma atrial natriuretic factor concentration, and plasma aldosterone concentration were measured initially and after 3 h of water immersion in 13 healthy sodium-replete men given either placebo or 20 micrograms of intranasal DDAVP. Guanosine 3',5'-cyclic monophosphate and urea excretion and urine osmolality were also determined. DDAVP inhibited the diuresis induced by water immersion in men: 758 +/- 168 (SE) ml/3 h in the placebo group vs. 159 +/- 28 ml/3 h in the DDAVP group (P less than 0.05). After 3 h of water immersion, plasma atrial natriuretic factor concentrations were increased from 11 +/- 2 to 20 +/- 4 pg/ml in the placebo group and from 14 +/- 2 to 33 +/- 4 pg/ml in the DDAVP group (P less than 0.05). Plasma aldosterone concentrations were decreased from 98 +/- 18 to 45 +/- 6 pg/ml in the placebo group (P less than 0.05) and from 54 +/- 17 to 25 +/- 5 pg/ml in the DDAVP group (P less than 0.05). Despite these changes in aldosterone and atrial natriuretic factor concentrations, which should increase sodium excretion, DDAVP decreased the natriuresis induced by water immersion in humans: 56 +/- 8 meq Na+/3 h in the placebo group vs. 36 +/- 6 meq Na+/3 h in the DDAVP group (P less than 0.05). DDAVP may be used to prevent the diuresis associated with central redistribution of blood volumes that occur during water immersion.(ABSTRACT TRUNCATED AT 250 WORDS)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Farrow</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Wayne State University School of Medicine, Detroit, Michigan 48201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banta</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Schallhorn</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>May</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Mers</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Cadaret</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Rydstedt</LastName><ForeName>L</ForeName><Initials>L</Initials></Author><Author ValidYN="Y"><LastName>Lockette</LastName><ForeName>W</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D018848">Controlled Clinical Trial</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Appl Physiol (1985)</MedlineTA><NlmUniqueID>8502536</NlmUniqueID><ISSNLinking>0161-7567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>4964P6T9RB</RegistryNumber><NameOfSubstance UI="D000450">Aldosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>85637-73-6</RegistryNumber><NameOfSubstance UI="D009320">Atrial Natriuretic Factor</NameOfSubstance></Chemical><Chemical><RegistryNumber>ENR1LLB0FP</RegistryNumber><NameOfSubstance UI="D003894">Deamino Arginine Vasopressin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CitationSubset>S</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Appl Physiol (1985). 1993 Oct;75(4):1917-8</RefSource><PMID Version="1">8282651</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000450" MajorTopicYN="N">Aldosterone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009320" MajorTopicYN="N">Atrial Natriuretic Factor</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001810" MajorTopicYN="N">Blood Volume</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003894" MajorTopicYN="N">Deamino Arginine Vasopressin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004231" MajorTopicYN="N">Diuresis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007101" MajorTopicYN="N">Immersion</DescriptorName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009318" MajorTopicYN="N">Natriuresis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1992</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1992</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1992</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">1400058</ArticleId><ArticleId IdType="doi">10.1152/jappl.1992.73.3.932</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>États-Unis</li></country><region><li>Michigan</li></region></list><tree><noCountry><name sortKey="Banta, G" sort="Banta, G" uniqKey="Banta G" first="G" last="Banta">G. Banta</name><name sortKey="Cadaret, L" sort="Cadaret, L" uniqKey="Cadaret L" first="L" last="Cadaret">L. Cadaret</name><name sortKey="Lockette, W" sort="Lockette, W" uniqKey="Lockette W" first="W" last="Lockette">W. Lockette</name><name sortKey="May, R" sort="May, R" uniqKey="May R" first="R" last="May">R. May</name><name sortKey="Mers, A" sort="Mers, A" uniqKey="Mers A" first="A" last="Mers">A. Mers</name><name sortKey="Rydstedt, L" sort="Rydstedt, L" uniqKey="Rydstedt L" first="L" last="Rydstedt">L. Rydstedt</name><name sortKey="Schallhorn, S" sort="Schallhorn, S" uniqKey="Schallhorn S" first="S" last="Schallhorn">S. Schallhorn</name></noCountry><country name="États-Unis"><region name="Michigan"><name sortKey="Farrow, S" sort="Farrow, S" uniqKey="Farrow S" first="S" last="Farrow">S. Farrow</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/Ncbi/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000224 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 000224 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= Ncbi
|étape= Merge
|type= RBID
|clé= pubmed:1400058
|texte= Vasopressin inhibits diuresis induced by water immersion in humans.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i -Sk "pubmed:1400058" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |